At the ASCB | EMBO 2017 meeting, we introduced z-Movi®, a new platform for cell interaction studies.
This new method enables direct and label-free screening and sorting of thousands of cells based on their interaction with cell or protein targets. z-Movi® is a breakthrough technology for research and development of personalized therapies, including immunotherapy. It is the first platform able to directly measure the strength of interaction, or avidity, between cells with specific targets and sort cells of interest, in a high-throughput and label-free manner.
Want to learn more about z-Movi®? Contact us for more information, a demo or a quote.
